It is reported that SETD1A is upregulated and promotes cancer development, including breast cancer, lung adenocarcinoma, colorectal cancer, and GC (Salz et al., 2014, 2015; Fang et al., 2018; Jin et al., 2018; Wu et al., 2020b). This evidence concerns the gene SETD1A and breast carcinoma.